It’s common for cancer programs and practices to struggle with timely treatment education, consent gathering, and adherence tracking, especially when an oral oncolytic is prescribed. These challenges are due in part to older solutions that are no longer benefiting all patients equally. To better address these concerns, Baptist Health South Florida, Miami Cancer Institute in Florida turned to technology solutions that were already being used by the health system and that were well understood by their healthcare teams and patients. By using these technologies and implementing existing staffing resources, Miami Cancer Institute staff are providing high-quality cancer care without having to dip deeper into its operating budget.

Guest:

Morgan Nestingen, MSN, APRN, AGCNS-BC, NEA-BC, OCN, ONN-CG Director of Nursing Services, Patient Intake and Navigation Baptist Health South Florida, Miami Cancer Institute

Resources:

• Improving Oral Oncolytic Compliance with Technology
• 2022 ACCC Innovator Award Details
• ACCC 39th National Oncology Conference
• Care Coordination: The Role of Pharmacy to Help Manage Patients with Cancer on Oral Oncolytics
• Leveraging Pharmacy Informatics to Standardize Pharmacists’ Review of Oral Oncolytics for Hospitalized Patients
• Defining the Role of Oncology Advanced Practitioners
• Improve Oral Oncolytic Workflow and Reduce Treatment Delays with a Pharmacist Collaborative Practice Agreement

This podcast is part of a special series on the 2022 ACCC Innovator Award winners. For a deeper dive into this content, visit ACCC’s Innovator Award website.